IVIG dose comparison in adults with chronic fatigue syndrome
Vollmer-Conna U et al. · 1997 · American Journal of Medicine
Indexed 2026-11-12.
Reported findings and study design
Reported findings
Double-blind comparison of IVIG at 0.5, 1 or 2 g/kg versus 1% albumin placebo. Three monthly infusions were followed by three months without treatment. Physical, psychological and functional outcomes were assessed.
Dose, route and schedule
Double-blind comparison of IVIG at 0.5, 1 or 2 g/kg versus 1% albumin placebo. Three monthly infusions were followed by three months without treatment. Physical, psychological and functional outcomes were assessed.
Protocol source ↗ · Original article abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Clinical outcomes | The trial found no specific benefit from IVIG over placebo at the doses studied. |
Historical case definitions and preparations differ across immunoglobulin studies.
Source for these results ↗ · Reviewed 2026-11-12
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- Historical case definitions and preparations differ across immunoglobulin studies.
Source access
Double-blind comparison of IVIG at 0.5, 1 or 2 g/kg versus 1% albumin placebo. Three monthly infusions were followed by three months without treatment. Physical, psychological and functional outcomes were assessed.
Source reviewed 2026-11-12.
Citation and original source
Original source: Vollmer-Conna U et al.. IVIG dose comparison in adults with chronic fatigue syndrome American Journal of Medicine 1997.
Molekul research summary: https://molekul.io/research/ivig-dose-cfs-1997. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry